Prostate Neuroendocrine Carcinoma — Trials

Prostate Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03582475	Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate	active not recruiting	Phase 1	15	Jonsson Comprehensive Cancer CenterOTHER	1	Nov 12, 2025	clinicaltrials
NCT06062745	Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT	recruiting	Phase 1	30	Brigham and Women's HospitalOTHER	1	Nov 5, 2025